Keystone Investors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Keystone Investors's LLY Position: Q4 2025 in Review
Keystone Investors increased its Eli Lilly (LLY) stake by 84% in Q4 2025, buying an estimated $4.17M and bringing the position to 9,560 shares worth $10.3M. The position accounts for 0.92% of the portfolio, ranked #25.
Keystone Investors first reported a position in LLY in Q3 2023 and has held it in 7 quarters since. The position peaked at $42.8M in Q4 2023. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Keystone Investors held 9,560 shares of Eli Lilly worth $10.3M as of Q4 2025.
- Keystone Investors bought 4,360 Eli Lilly shares in Q4 2025, an estimated $4.17M.
- Eli Lilly made up 0.92% of Keystone Investors's portfolio in Q4 2025, its #25 holding.
- Keystone Investors first reported a position in Eli Lilly in Q3 2023 and has held it in 7 quarters since.
- Keystone Investors's Eli Lilly position peaked at $42.8M in Q4 2023.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Keystone Investors's 13F filing for Q4 2025, filed 13 Feb 2026.